Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Open-Label Phase 4 Study of CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules in Parkinson's Disease Patients (IRB 298113)


Collapse Overview 
Collapse sponsor award id
IPX203-401-23


Collapse Biography 

Collapse Time 
Collapse start date
2025-02-10

Collapse end date
2035-02-09